| Bioactivity | Crinecerfont (SSR-125543) hydrochloride is a potent, orally active, non-peptide CRF1 receptor antagonist. Crinecerfont can be used for Classic congenital adrenal hyperplasia (CAH) research[1]. |
| Target | IC50: CRF1 receptor |
| Name | Crinecerfont |
| CAS | 752253-39-7 |
| Formula | C27H28ClFN2OS |
| Molar Mass | 483.04 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia (CAHtalyst). |
Crinecerfont
CAS: 752253-39-7 F: C27H28ClFN2OS W: 483.04
Crinecerfont (SSR-125543) hydrochloride is a potent, orally active, non-peptide CRF1 receptor antagonist. Crinecerfont c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.